HAYWARD, Calif., Feb. 15, 2011 /PRNewswire/ -- Solta Medical, Inc. , the pioneer in fractional resurfacing and non-invasive skin tightening and a global market leader in aesthetic skin treatments, today announced that it has named Linda Graebner to its Board of Directors, effective immediately. Ms. Graebner is the founder and managing partner of LG Associates, a consulting firm which specializes in creating and implementing business growth plans for consumer, manufacturing and retail businesses. Her appointment brings the total number of directors on the Solta board to seven.
"Linda's focus throughout her career has been in the consumer products industry, an emerging market for Solta," said Stephen J. Fanning, Chairman of the Board, President and CEO of Solta Medical, Inc. "She has extensive executive experience in driving the growth and development of leading consumer brands and companies. Her expertise ranges from strategic development and capital formation to manufacturing and product innovation. She is well-versed in the execution of targeted e-commerce initiatives and retail distribution to drive awareness and sales of consumer products. We believe Linda will add valuable insight as we expand into the high-end personal care market, and we look forward to her contributions."
Prior to founding LG Associates, Ms Graebner was the President and CEO of Tilia Inc., a leading marketer and manufacturer of specialty kitchen products. During her 12 year tenure at Tilia, she created and executed the strategic plan for the company that resulted in a new category in the housewares industry and a financial turnaround. Under her leadership, Tilia expanded its product line, drove significant cost savings by shifting product sourcing from Europe to the Far East, and strengthened its financial structure. The company grew from $9 million in revenue with significant losses when Ms. Graebner joined Tilia to over $200 million in revenue with strong EBITDA and cash flow prior to its sale to Jarden Corporation in 2002.
Ms. Graebner's experience also includes various executive level positions in sales and marketing, new business development and R&D at Dole Food Company, a $3 billion food producer. Prior to Dole, Ms. Graebner held senior marketing, business development and strategic planning positions at James River Corporation, as well as Crown Zellerbach, prior to its acquisition by James River. She began her career with Booz, Allen & Hamilton.
"I am excited to join the Solta Medical Board as the Company begins to expand its innovative aesthetic solutions into the high-end personal care market," commented Ms. Graebner. "Solta Medical has built a strong foundation and reputation with its core physician customer base. It has successfully begun initial product innovations and marketing efforts to bring awareness of its unique, safe and effective treatments for a variety of skin conditions directly to consumers, and I look forward to helping the Company continue its momentum as a member of the Board."
In addition to Solta Medical, Ms. Graebner is currently serving on several Boards: Distant Lands Coffee and Evriholder Products LLP (kitchen, cleaning and personal care). She has served as the Chairman of the Board of the International Housewares Association (IHA) and currently leads a Bay Area CEO Group sponsored by IHA. She also serves as Group Chair of the Silicon Valley Chapter of the Women Presidents' Organization and as a Chair of the Chief Executive Council in San Francisco. Ms. Graebner has a B.S. degree in mathematics from Purdue University and an M.B.A. from Stanford University.
ABOUT SOLTA MEDICAL, INC.
Solta Medical, Inc. is a global leader in the medical aesthetics market providing innovative, safe, and effective solutions for patients that enhance and expand the practice of medical aesthetics for physicians. The company offers products to address a range of skin issues under the industry's four premier brands: Thermage®, Fraxel®, Isolaz®, and CLARO®. Thermage is an innovative, non-invasive radiofrequency procedure for tightening and contouring skin. As the leader in fractional laser technology, Fraxel delivers minimally invasive clinical solutions to resurface aging and sun damaged skin. Isolaz is the only laser or light based system indicated for the treatment of inflammatory acne, comedonal acne, pustular acne, and mild-to-moderate inflammatory acne. CLARO is a personal care acne system that is the only FDA cleared over-the-counter IPL device that uses a powerful combination of both heat and light to clear skin quickly and naturally. Since 2002, approximately one million Thermage, Fraxel and Isolaz procedures have been performed in over 100 countries. For more information about Solta Medical, call 1-877-782-2286 or log on to http://www.solta.com/.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, including statements regarding the anticipated shipment dates of the newly announced products and contributions of the new products to future growth. Forward-looking statements are based on management's current expectations and are subject to risks and uncertainties, which may cause actual results to differ materially from the forward looking statements contained herein. Factors that might cause such a difference include the possibility that the market for the sale of these products and initiatives does not develop as expected or that difficulties arise in the production and shipment of these products arise. Further information on potential risk factors that could affect Solta Medical's business are detailed in its Form 10-Q for the quarter ended September 30, 2010. Solta Medical undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events.
© 2010 Solta Medical, Inc. All rights reserved. Thermage, Fraxel, Fraxel re:store, Isolaz, Clear+Brilliant, and Solta Medical are trademarks or registered trademarks of Solta Medical, Inc. or its subsidiaries.
Solta Medical, Inc.
CONTACT: Jack Glenn, Chief Financial Officer of Solta, +1-510-786-6890;
or Investors, Doug Sherk or Jenifer Kirtland, jkirtland@evcgroup.com, both of
EVC Group for Solta, +1-415-896-6820
Web Site: http://www.solta.com/
